News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
700,392 Results
Type
Article (40307)
Company Profile (254)
Press Release (659831)
Multimedia
Podcasts (51)
Webinars (12)
Section
Business (204491)
Career Advice (2019)
Deals (35450)
Drug Delivery (95)
Drug Development (81177)
Employer Resources (172)
FDA (16206)
Job Trends (14916)
News (345695)
Policy (32571)
Tag
Academia (2582)
Accelerated approval (5)
Adcomms (21)
Allergies (85)
Alliances (49531)
ALS (89)
Alzheimer's disease (1394)
Antibody-drug conjugate (ADC) (124)
Approvals (16208)
Artificial intelligence (256)
Autoimmune disease (21)
Automation (16)
Bankruptcy (360)
Best Places to Work (11685)
BIOSECURE Act (19)
Biosimilars (105)
Biotechnology (181)
Bladder cancer (78)
Brain cancer (27)
Breast cancer (278)
Cancer (2258)
Cardiovascular disease (174)
Career advice (1684)
Career pathing (30)
CAR-T (152)
Cell therapy (425)
Cervical cancer (19)
Clinical research (66070)
Collaboration (835)
Company closure (1)
Compensation (533)
Complete response letters (20)
COVID-19 (2590)
CRISPR (40)
C-suite (244)
Cystic fibrosis (100)
Data (2206)
Decentralized trials (2)
Denatured (18)
Depression (49)
Diabetes (270)
Diagnostics (6371)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (120)
Drug pricing (99)
Drug shortages (25)
Duchenne muscular dystrophy (93)
Earnings (86691)
Editorial (38)
Employer branding (21)
Employer resources (146)
Events (112652)
Executive appointments (724)
FDA (17472)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (753)
Gene editing (104)
Generative AI (19)
Gene therapy (302)
GLP-1 (713)
Government (4422)
Grass and pollen (4)
Guidances (67)
Healthcare (18844)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (116)
Indications (29)
Infectious disease (2732)
Inflammatory bowel disease (137)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (97)
Interviews (314)
IPO (16520)
IRA (40)
Job creations (3646)
Job search strategy (1430)
Kidney cancer (10)
Labor market (38)
Layoffs (469)
Leadership (17)
Legal (7918)
Liver cancer (75)
Lung cancer (320)
Lymphoma (154)
Machine learning (7)
Management (58)
Manufacturing (305)
MASH (67)
Medical device (13397)
Medtech (13402)
Mergers & acquisitions (19477)
Metabolic disorders (686)
Multiple sclerosis (80)
NASH (16)
Neurodegenerative disease (94)
Neuropsychiatric disorders (30)
Neuroscience (1945)
NextGen: Class of 2025 (6536)
Non-profit (4490)
Now hiring (39)
Obesity (365)
Opinion (205)
Ovarian cancer (75)
Pain (88)
Pancreatic cancer (83)
Parkinson's disease (152)
Partnered (21)
Patents (234)
Patient recruitment (112)
Peanut (46)
People (57423)
Pharmaceutical (64)
Pharmacy benefit managers (18)
Phase I (20583)
Phase II (29092)
Phase III (21671)
Pipeline (1204)
Policy (140)
Postmarket research (2567)
Preclinical (8768)
Press Release (64)
Prostate cancer (106)
Psychedelics (30)
Radiopharmaceuticals (246)
Rare diseases (379)
Real estate (5924)
Recruiting (65)
Regulatory (22304)
Reports (46)
Research institute (2340)
Resumes & cover letters (350)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (73)
Series A (132)
Series B (86)
Service/supplier (11)
Sickle cell disease (52)
Special edition (16)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3590)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (40)
The Weekly (31)
Vaccines (689)
Venture capitalists (41)
Weight loss (234)
Women's health (35)
Worklife (16)
Date
Last 7 days (897)
Last 30 days (2482)
Last 365 days (32678)
2025 (10765)
2024 (35303)
2023 (40161)
2022 (51251)
2021 (55793)
2020 (54154)
2019 (46601)
2018 (35087)
2017 (32171)
2016 (31585)
2015 (37659)
2014 (31432)
2013 (26461)
2012 (28657)
2011 (29324)
2010 (27376)
Location
Africa (719)
Alabama (53)
Alaska (7)
Arizona (232)
Arkansas (13)
Asia (37948)
Australia (6215)
California (6140)
Canada (2018)
China (525)
Colorado (266)
Connecticut (274)
Delaware (148)
Europe (81638)
Florida (914)
Georgia (206)
Idaho (57)
Illinois (544)
India (25)
Indiana (309)
Iowa (11)
Japan (162)
Kansas (104)
Kentucky (24)
Louisiana (10)
Maine (62)
Maryland (894)
Massachusetts (4586)
Michigan (220)
Minnesota (392)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (63)
New Hampshire (63)
New Jersey (1729)
New Mexico (28)
New York (1750)
North Carolina (969)
North Dakota (8)
Northern California (2683)
Ohio (204)
Oklahoma (14)
Oregon (34)
Pennsylvania (1379)
Puerto Rico (12)
Rhode Island (33)
South America (1099)
South Carolina (23)
South Dakota (1)
Southern California (2304)
Tennessee (102)
Texas (909)
United States (23175)
Utah (180)
Virginia (146)
Washington D.C. (64)
Washington State (552)
West Virginia (3)
Wisconsin (54)
700,392 Results for "mivi neuroscience inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
MIVI Neuroscience™ Presents Primary Endpoint Results from the EvaQ Trial — at the 2024 International Stroke Conference
MIVI Neuroscience, Inc. (Eden Prairie, MN) announces the primary endpoint results of its EvaQ Trial, a prospective, multi-center, global, single arm, FDA-regulated IDE trial study to evaluate the safety and effectiveness of the MIVI Q™ Revascularization System for treating acute ischemic stroke.
February 8, 2024
·
3 min read
Press Releases
Johnson & Johnson Closes Landmark Intra-Cellular Therapies, Inc. Acquisition to Solidify Neuroscience Leadership
April 2, 2025
·
10 min read
Neurodegenerative disease
Denali Goes All In on Neuroscience’s Thorniest Hurdle: Crossing the Blood-Brain Barrier
After some high-profile crashes, the one-time biotech darling is inching toward success with its Hunter syndrome treatment, which today began a rolling BLA for accelerated approval.
April 2, 2025
·
5 min read
·
Dan Samorodnitsky
BioMidwest
Clinical Trial Enrollment Complete for Study of MIVI Q™ Revascularization System that Treats Acute Ischemic Stroke
MIVI Neuroscience, Inc., innovator of next-generation neurointerventional medical devices, today announced that it has completed enrollment in the company’s clinical trial to assess the safety and effectiveness of the Q™ Revascularization System for the treatment of acute ischemic stroke (EVAQ Trial).
May 3, 2023
·
2 min read
Press Releases
Dalen Meeter Joins Aspen Neuroscience as Chief Financial Officer
May 1, 2025
·
2 min read
Press Releases
Alto Neuroscience to Participate in the JonesResearch Virtual CNS Day
April 22, 2025
·
1 min read
Pipeline
AstraZeneca Abandons Neuroscience, Prioritizes Weight Loss, Immunology
Following the recent discontinuations of assets in Alzheimer’s and migraine, AstraZeneca is stepping away from neuro altogether.
April 29, 2025
·
3 min read
·
Tristan Manalac
Press Releases
Johnson & Johnson Strengthens Neuroscience Leadership with Acquisition of Intra-Cellular Therapies, Inc.
January 13, 2025
·
20 min read
Press Releases
Precision Neuroscience Adds Med-Tech Veterans To Accelerate Commercialization
May 1, 2025
·
3 min read
Press Releases
Gate Neurosciences Strengthens Focus on the Synapse as a Therapeutic Target with Acquisition of Boost Neuroscience
February 19, 2025
·
4 min read
1 of 70,040
Next
